RESUMEN
OBJECTIVE: To investigate non-surgical periodontal therapy by 18F-fluorodeoxyglucose (2-[18 F]FDG) uptake using positron emission tomography (PET) integrated with computed tomography (CT). SUBJECTS: Eighty-five patients with peripheral artery disease and severe periodontitis-randomized into three groups receiving therapy with (PT1; n = 29) or without (PT2; n = 28) systemic antibiotics or no treatment (controls: n = 28)-underwent nuclear imaging at baseline and at 3 months. RESULTS: Clinical inflammation (periodontal inflamed surface area; PISA) did not significantly differ across the groups at baseline (p = 0.395) but was significantly reduced at 3 months (p < 0.001), and significantly more so in the PT1/PT2 groups than in the control group (p < 0.001/=0.025) and in the PT1 than in the P2 group (p = 0.001). Radiotracer uptake was measured in both jaws using maximum and mean 'standardized uptake values' (SUVmax , SUVmean ) and 'target-to-background ratios' (TBRmax , TBRmean ). At 3 months, reductions were relatively small in absolute numbers and fell short of revealing correlations with PISA or significant differences across the groups. Still, they were very consistent in both treatment groups, whereas reductions were not consistently seen in the control group. CONCLUSIONS: 2-[18 F]FDG PET/CT scans did reflect the clinical effects of periodontal treatment very consistently but, for reasons yet to be clarified, less closely than expected.
RESUMEN
Nutrition plays a crucial role in the pathophysiology and management of peripheral arterial disease (PAD) and periodontal disease (PD). As PD can have profound effects on an individual's functional ability to eat and can affect nutrient intake, we aimed to evaluate the role of PD severity on dietary intake (DI) and quality in PAD patients and compare it with current dietary recommendations for CVD. PD stages of 421 consecutive PAD patients were determined according to a standardised basic periodontal examination (Periodontal Screening and Recording Index) ('healthy', 'gingivitis', 'moderate periodontitis' and 'severe periodontitis'). Dietary intake (24-h recall), dietary quality (food frequency index (FFI)) and anthropometrical data were assessed. Nutritional intake was stratified according to the severity of PD. No significant differences in DI of macronutrients, nutrients relevant for CVD and FFI were seen between the PD stages. Only median alcohol intake was significantly different between gingivitis and severe periodontitis (P = 0·001), and positively correlated with PD severity (P = 0·001; r 0·159). PD severity and the patient's number of teeth showed no correlation with investigated nutritional parameters and FFI. Few subjects met the recommended daily intakes for fibre (5 %), SFA (10 %), Na (40 %) and sugar (26 %). Macronutrient intake differed from reference values. In our sample of patients with PAD and concomitant PD, we found no differences in DI of macronutrients, nutrients relevant for CVD and diet quality depending on PD severity. The patients' nutrition was, however, poor, deviating seriously from dietary guidelines and recommendations.
Asunto(s)
Dieta/efectos adversos , Enfermedades Periodontales/etiología , Enfermedad Arterial Periférica/complicaciones , Anciano , Registros de Dieta , Femenino , Alimentos/clasificación , Humanos , Masculino , Persona de Mediana Edad , Valor NutritivoRESUMEN
This study investigated the effects of hydration status and fluid availability on appetite and energy intake. Sixteen males completed four 24 h trials, visiting the laboratory overnight fasted on two consecutive days. Standardised foods were provided during the 24 h and on day two an ad-libitum semi-solid porridge breakfast was provided. Water intake during the 24 h (0 or 40 mLâ kg(-1)) and fluid provision during the ad-libitum breakfast were manipulated so subjects were euhydrated with (EU-F) and without fluid (EU-NF) available at breakfast; and hypohydrated with (HYPO-F) and without fluid (HYPO-NF) available at breakfast. Blood samples (0 and 24 h), urine samples (0-24 h) and subjective responses (0, 24 and 24.5 h) were collected. HYPO trials decreased body mass by ~1.8%. Serum and urine osmolality increased and plasma volume decreased during HYPO trials (P <0.001). Total urine output was greater during EU than HYPO trials (P <0.001). Ad-libitum energy intake was not different between trials: 2658 (938) kJ (EU-F), 2353 (643) kJ (EU-NF), 2295 (529) kJ (HYPO-F), 2414 (954) kJ (HYPO-NF), (P = 0.131). Fluid intake was ~200 mL greater during HYPO-F than EU-F (P <0.01). There was an interaction effect for thirst (P < 0.001), but not hunger or fullness. These results demonstrate that mild hypohydration produced by inadequate fluid intake and fluid availability during eating does not influence ad-libitum energy intake of a semi-solid breakfast, at least in healthy young males.
Asunto(s)
Apetito , Desayuno , Deshidratación , Ingestión de Líquidos , Ingestión de Energía , Respuesta de Saciedad , Equilibrio Hidroelectrolítico , Adulto , Deshidratación/fisiopatología , Ingestión de Líquidos/fisiología , Ingestión de Alimentos , Ayuno , Humanos , Masculino , Concentración Osmolar , Saciedad , Sed , Micción , Adulto JovenRESUMEN
BACKGROUND AND AIMS: Observational studies support an association between periodontitis and cardiovascular diseases. The study objective was to assess vascular inflammation after periodontal treatment in patients with peripheral arterial disease. METHODS: Ninety patients with peripheral arterial disease (PAD) and severe periodontitis were enrolled in a randomized, controlled trial. Thirty patients underwent non-surgical periodontal therapy and received additional systemic antibiotics (PT1 group), while 30 patients received the same therapy without antibiotics (PT2 group). The remaining thirty patients did not receive periodontal therapy (CG, control group). The primary outcome of this treatment was a reduction in vascular inflammation three months after periodontal treatment as determined by 18F-FDG PET/CT values. Secondary outcomes were changes in the inflamed periodontal surface area (PISA) and other periodontal parameters, changes in vascular biomarkers, and adverse cardiovascular events. RESULTS: After three months of treatment, a significant improvement in periodontal health was observed in the treatment groups. However, no difference in the primary outcome in the aorta was observed in the three study groups (median target to background ratio follow-up/baseline, PT1 1.00; 95% CI 0.97-1.10, PT2 1.00; 95% CI 0.98-1.1, CG 1.1; 95% CI 0.99-1.1, p = 0.75). No significant differences were detected in most diseased segments and active segments. In addition, no differences were observed in 18F-FDG uptake in the carotid, iliac, femoral, and popliteal arteries. No differences with regard to relative changes in vascular biomarkers were noted, and no serious cardiovascular adverse events occurred. CONCLUSIONS: Periodontal treatment was effective and safe but did not reduce vascular inflammation in patients with PAD.